Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Average Rating of “Buy” by Brokerages
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight brokerages that are covering the company, MarketBeat reports. Six analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year target price among […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight brokerages that are covering the company, MarketBeat reports. Six analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1 year target price among […]